ViGenCell announced on the 24th that its advanced biopharmaceutical Good Manufacturing Practices (GMP) center has obtained a license for its cell processing facility, allowing it to comply with the recently enacted "Act on Safety and Support for Advanced Regenerative Medicine and Advanced Biopharmaceuticals." ViGenCell plans to expand its business areas, including contract manufacturing organization (CMO) and contract development and manufacturing organization (CDMO), focusing on clinical research for various rare disease indications, particularly the VT-EBV-N (an NK/T cell lymphoma treatment) and VT-Tri(1)-A (an acute myeloid leukemia treatment), which are currently in advanced clinical stages. Additionally, under the revised Act, the company intends to expand discussions with numerous regenerative medicine institutions and clinical research entities to facilitate advancements in advanced regenerative medicine treatments.
Yuhan Corporation announced on the 24th the launch of its premium nutritional supplement "Mag BEX," which contains four types of magnesium along with traditional herbal ingredients such as peony and licorice. Mag BEX is the first in South Korea to include four types of magnesium. Its scientific formulation combines one inorganic salt with three organic salts to enhance magnesium absorption and longevity. The inorganic salt and organic salts serve to quickly supply nutrients and increase absorption rates, respectively. By adding peony and licorice ingredients, it provides a complex care approach that promotes muscle relaxation and psychological stability.
Daewoong Pharmaceutical announced on the 24th that it has discovered a botulinum type A strain through a soil beneficial microorganism discovery project conducted with Noah Biotech. The Noah Biotech research team successfully isolated and identified the botulinum type A strain from one sample collected from domestic livestock farms suspected of botulism due to severe contamination or livestock deaths. Noah Biotech is a bio company established with the goal of exploring, isolating, and securing beneficial microorganisms to enhance the quality of life. With this discovery, Daewoong has secured a total of seven botulinum strains both domestically and internationally.
Daewoong Pharmaceutical announced on the 24th that it will officially launch its health supplement brand "Dr. Bear" at Daiso stores. Sales will begin at all Daiso outlets starting today, with the product lineup including 26 types focused on liver and eye health, blood pressure, blood sugar, blood flow management, and body fat management. Through the launch of Dr. Bear at Daiso, Daewoong expects consumers to be able to easily purchase products at reasonable prices. The price for a month's supply of Dr. Bear is set affordably at around 3,000 to 5,000 won.
JW Pharmaceutical announced on the 24th the launch of its health supplement "100 Billion Probiotics Max" aimed at improving intestinal health. This product contains probiotics that can aid in the proliferation of beneficial bacteria and inhibit harmful bacteria. It applies a U.S. patented coating technology that enhances the survival rate of probiotics within the body, ensuring that probiotics can reach the intestines reliably.
SK Bioscience announced on the 24th that it has been certified as one of the "2025 best companies to work for in South Korea" for three consecutive years. CEO Lee Dong-hoon was selected as the "most respected CEO in Korea." SK Bioscience was also recognized as a "best company for millennials," "best company for working moms," "best company for parents," and among the "top 100 companies to work for."
Merz Aesthetics Korea announced on the 24th that it has secured the top position in the "2025 best companies to work for in South Korea." Merz has made it to the "top 100 companies to work for" for three consecutive years, moving up from 10th last year to 1st this year. Additionally, the company has received awards for "global ESG human rights management certification," "best company for parents," "most respected CEO," "proud working mom," "GPTW Pioneer Award," and "GPTW Innovation Leader."
The Yuhan Foundation, a foundation of Yuhan Corporation, announced on the 24th that it has held a scholarship award ceremony for 141 students, including those from the Catholic Kkottongnae University, at the "2025 Yuhan Foundation Scholarship Award Ceremony." These students will receive their annual tuition split over two semesters. Since its establishment in 1970, the Yuhan Foundation has awarded complete tuition coverage to outstanding university students every year up until their graduation. The total number of scholarship recipients exceeds 8,700, with a funding amount of over 3.1 billion won.
Dongkook Pharmaceutical announced on the 24th that it held a symposium for the launch of its botulinum toxin "Bienox" at the Chaebit Island Anniversary Hall in Banpo-dong, Seocho-gu, Seoul, on the 22nd. The symposium aimed to officially introduce Bienox and share the latest procedural trends utilizing the product. Approximately 100 medical professionals attended the event, which provided education on Dongkook Pharmaceutical's medical aesthetic (DKMA) items and procedures. The meeting offered practical and safe procedural guidelines that can be applied in medical institutions.
Dong-A Pharmaceutical announced on the 24th that its trouble care specialized brand Partion will launch two types of "Norskanine Sun Care" products. Reflecting consumers' concerns about trouble arising after using sunscreen, Partion has developed low-irritation sun care products: "Norskanine Trouble Comfort Moisturizing Sunscreen" and "UV Aging Barrier Sunscreen Serum" that incorporate trouble care expertise. Both products feature strong UV protection with SPF 50+ and PA++++ ratings and have completed sensitivity tests for skin irritation, making them safe for sensitive skin.
Bucheon Jaseng Oriental Hospital announced on the 24th that it has entered into a main sponsorship agreement (MOU) with Bucheon FC. In accordance with this MOU, Bucheon Jaseng Oriental Hospital will provide medical services for spinal and joint health management to the Bucheon FC professional team, youth team, coaching staff, administrative office, members, and supporters. The hospital has also promised generous support, including dispatching medical personnel during games and training sessions. Throughout this year, the hospital plans to take part as the main sponsor of Bucheon FC by providing various forms of support toward the goal of promotion to K League 1.
Neurophet, a company specializing in artificial intelligence (AI) solutions for brain disease imaging, announced on the 24th that it will participate in the 10th American Committee for Treatment Research in Multiple Sclerosis Forum (ACTRIMS 2025) to be held from the 27th of this month to the 1st of the next month (local time) in Florida, USA. At this forum, Neurophet will introduce its multiple sclerosis imaging analysis software "Neurophet AQUA MS" for the first time with a dedicated booth.